Mavacamten (camzyos) 5 MG and pomalidomide (pomalyst) 2 MG

Ended Awarded Last action

Contract number
36C24526N0288
Awardee
Awarding agency
Obligated
$232,761

Award facts

Contract value 100% obligated
$232,761.28 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Memphis, TN 38141, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $49,310

About this award

Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company under the Pharmaceuticals and Drugs (FSS-61-IB) federal supply schedule, with a ceiling value of $232,761.28 and an award date of February 17, 2026. The call covers MAVACAMTEN (CAMZYOS) 5 mg and POMALIDOMIDE (POMALYST) 2 mg, pharmaceutical products for specialty oncology treatment. Performance occurs at Memphis, Tennessee, with ultimate completion by September 30, 2026. The call is firm fixed price with no small business set-aside designation.

Quick answers

Who was awarded contract 36C24526N0288?

36C24526N0288 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 17, 2026.

How much is contract 36C24526N0288 worth?

The government has obligated $232,761 on 36C24526N0288.

Is contract 36C24526N0288 an order under another contract?

Yes. 36C24526N0288 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24526N0288 competed?

The extent of competition for 36C24526N0288 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award